Lungs News and Research

RSS

Scientists demonstrate the link between cancer and diesel fumes

Scientists here are the first to demonstrate that the link between diesel fume exposure and cancer lies in the ability of diesel exhaust to induce the growth of new blood vessels that serve as a food supply for solid tumors.

2 Sep 2009

NCI to announce the results of follow-up study of PharmaGap's lead drug GAP-107B8

PharmaGap Inc. (TSX-V: GAP; OTC.BB: PHRGF) ("PharmaGap" or "the Company") today announced that results are expected during September from the United States National Cancer Institute (NCI) follow-up study of the company's lead drug GAP-107B8.

2 Sep 2009

The CyberKnife Robotic Radiosurgery System deployed at the CHUM

In operation since recently at the Centre hospitalier de l'Université de Montréal (CHUM), the CyberKnife(R) Robotic Radiosurgery System, is revolutionizing the treatment of both cancerous and non-cancerous tumors anywhere in the body. Used in radiation oncology, the CyberKnife System is the latest word in radiosurgery technology. Designed to destroy tumours using radiation beams, it is the first system of its kind to treat tumors non-invasively to be installed in Canada.

2 Sep 2009

SUPERVALU PHARMACIES available to administer flu shots

With an eye on convenience, cost and consumer education, SUPERVALU PHARMACIES this year has expanded its traditional flu shot offering to help ease some of the anxieties the upcoming flu season may bring.

2 Sep 2009

CT screening for coronary artery calcification can cause radiation-induced cancer

A study based on computer modeling of radiation risk suggests that widespread screening for the buildup of calcium in the arteries using computed tomography scans would lead to an estimated 42 additional radiation-induced cancer cases per 100,000 men and 62 cases per 100,000 women, according to a report in the July 13 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

2 Sep 2009

St. Luke's Episcopal Hospital uses CyberKnife robotic radiosurgery system for treating tumours

St. Luke's Episcopal Hospital is the first hospital in Houston to feature the CyberKnife((R)), a noninvasive alternative to surgery for the treatment of both cancerous and non-cancerous tumors.

2 Sep 2009

New study on behaviour of telomeres during cell division in cancerous human cells

A process that limits the number of times a cell divides works much differently than had been thought, opening the door to potential new anticancer therapies, researchers at UT Southwestern Medical Center report in the Aug. 7 issue of the journal Cell.

2 Sep 2009

Heidelberg neuropathologists detect astrocytomas that can deactivate the "death receptor"

Malignant brain tumors often fail to respond to promising new medication. Researchers in Heidelberg have discovered a mechanism and a tumor marker for the development of this resistance. A "death receptor" can possibly provide information as to how great the chances of success are for chemotherapy. At the same time, it offers a new approach for promising brain tumor therapy.

2 Sep 2009

Lab results shows H1N1 virus does not change into virulent superbug

A laboratory study by University of Maryland researchers suggests that some of the worst fears about a virulent H1N1 pandemic flu season may not be realized this year, but does demonstrate the heightened communicability of the virus.

2 Sep 2009

Polymyositis and dermatomyositis affected patients more prone to cardiovascular diseases

Patients suffering from two serious autoimmune disorders which cause muscular inflammation are at increased risk of developing cardiovascular disease, says a group of Montreal researchers. Dr. Christian A. Pineau and his team at the Research Institute of the McGill University Health Centre (RI-MUHC) have linked muscular inflammation to increased cardiovascular risk for the first time.

2 Sep 2009

New computer software capable of sifting through hundreds of cancer causing genetic mutations

Johns Hopkins engineers have devised innovative computer software that can sift through hundreds of genetic mutations and highlight the DNA changes that are most likely to promote cancer.

1 Sep 2009

New clinical predictors required to determine future asthma attacks

Screening tests used to predict asthma activity in patients may have little tracking success when applied to people with persistent disease who are adhering to their health care regimens, UT Southwestern Medical Center physician report.

1 Sep 2009

Hospital executives worry about reform uncertainties

Federal authorities are conducting a thorough investigation of Saint Francis Hospital and Medical Care Center in Connecticut. Hartford Business Journal Online reports: "The failure of an oxygenator — medical equipment often used in cardiac surgery in conjunction with a heart-lung machine — triggered a complaint by the state of Connecticut to the Centers for Medicare & Medicaid [Services] (CMS), said Roseanne Pawelec, an agency spokeswoman.

1 Sep 2009

Rite Aid pharmacies to offer regular seasonal flu shots throughout the flu season

Many Rite Aid pharmacists have already been giving regular seasonal flu shots following the Centers for Disease Control and Prevention (CDC) advice that anyone who wishes to reduce the risk of getting the regular seasonal flu get a flu shot as soon as they are available.

31 Aug 2009

Health Net urges Americans to have their blood cholesterol measured

Tomorrow, September 1, marks the start of National Cholesterol Education Month. In support of this educational effort, Health Net, Inc., (NYSE: HNT) is encouraging those who haven't yet done so, to have their blood cholesterol measured and, if it's high, to embark on a cholesterol-lowering program.

31 Aug 2009

Cancer researcher to serve as Peregrine Pharmaceuticals' clinical advisor for bavituximab cancer program

Peregrine Pharmaceuticals, Inc., today announced that noted cancer researcher Bruce Chabner, M.D., will serve as a clinical advisor to the company on the design of clinical trials for the bavituximab cancer program.

31 Aug 2009

Cyberknife Robotic Radiosurgery System to be showcased at the ESTRO conference

Accuray Incorporated, a global leader in the field of radiosurgery, announced today that the company will showcase the treatment planning capabilities of the CyberKnife(R) Robotic Radiosurgery System at the 10th Biennial European Society for Therapeutic Radiology and Oncology (ESTRO) Conference on Physics and Radiation Technology for Clinical Radiotherapy in Maastricht, The Netherlands.

31 Aug 2009

FDA approves the usage of Valcyte for preventing CMV disease in pediatric patients

Roche announced today that the U.S. Food and Drug Administration (FDA) has approved Valcyte(R) (valganciclovir hydrochloride) for the prevention of cytomegalovirus (CMV) disease in pediatric kidney and heart transplant patients (4 months to 16 years of age) at high risk of developing CMV disease.

31 Aug 2009

Cancer Immunotherapy Index of ten cancer immunotherapy stocks increases by 23%

The Cancer Immunotherapy Index of ten leading cancer immunotherapy stocks increased 23% since its inception July 10, 2009. The CI Index was developed by Mentor Capital as a peer group index against which investors could bench mark stock performance in the rapidly growing immunotherapy sector.

29 Aug 2009

Forest Laboratories announces phase 3 trial results for roflumilast

Forest Laboratories, Inc., an international pharmaceutical manufacturer and marketer and Nycomed, a privately owned pharmaceutical company, today announced that results of four phase III trials have been published in the prestigious peer-reviewed medical journal The Lancet showing that roflumilast, a phosphodiesterase 4 (PDE4) inhibitor, improved lung function and reduced exacerbations in patients with moderate to severe COPD.

28 Aug 2009

Lungs News and Research

Scientists demonstrate the link between cancer and diesel fumes

NCI to announce the results of follow-up study of PharmaGap's lead drug GAP-107B8

The CyberKnife Robotic Radiosurgery System deployed at the CHUM

SUPERVALU PHARMACIES available to administer flu shots

CT screening for coronary artery calcification can cause radiation-induced cancer

St. Luke's Episcopal Hospital uses CyberKnife robotic radiosurgery system for treating tumours

New study on behaviour of telomeres during cell division in cancerous human cells

Heidelberg neuropathologists detect astrocytomas that can deactivate the "death receptor"

Lab results shows H1N1 virus does not change into virulent superbug

Polymyositis and dermatomyositis affected patients more prone to cardiovascular diseases

New computer software capable of sifting through hundreds of cancer causing genetic mutations

New clinical predictors required to determine future asthma attacks

Hospital executives worry about reform uncertainties

Rite Aid pharmacies to offer regular seasonal flu shots throughout the flu season

Health Net urges Americans to have their blood cholesterol measured

Cancer researcher to serve as Peregrine Pharmaceuticals' clinical advisor for bavituximab cancer program

Cyberknife Robotic Radiosurgery System to be showcased at the ESTRO conference

FDA approves the usage of Valcyte for preventing CMV disease in pediatric patients

Cancer Immunotherapy Index of ten cancer immunotherapy stocks increases by 23%

Forest Laboratories announces phase 3 trial results for roflumilast

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News